How aspirin and omega-3 may reduce cancer risk

Latest Posts

By Lizzy

Low doses of the recombinant T-cell growth factor interleukin 2 (IL-2, aldesleukin, Proleukin) were well tolerated among patients with moderate-to-severe ulcerative colitis in a small...

Comments closed

Do Mask-Wearing Policies Make a Difference?

By Lizzy

The 24-hour news cycle is just as important to medicine as it is to politics, finance, or sports. At MedPage Today, new information is posted...

Comments closed

Intestinal Biomarkers Respond to Ozanimod

By Lizzy

Treatment with oral ozanimod (Zeposia) reduced markers of intestinal inflammation among patients with moderately to severely active ulcerative colitis, confirming previously demonstrated clinical benefits. Levels...

Comments closed

Impact of Masks; High vs Low Blood Oxygen: It’s TTHealthWatch!

By Lizzy

TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine, and Rick Lange, MD, president...

Comments closed

COVID-19 Poses Special Challenges to Cancer Care

By Lizzy

This story was originally published on March 25, 2020. As part of MedPage Today's review of top stories in 2020, we are republishing it, along...

Comments closed

A new clinical trial suggests that taking aspirin and an omega-3 fatty acid can decrease the number of precancerous growths in the colon.

Source: MedicalNewsToday.com